Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BAK1 Antikörper (N-Term)

BAK1 Reaktivität: Human, Maus WB, ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN541234
  • Target Alle BAK1 Antikörper anzeigen
    BAK1 (BCL2-Antagonist/killer 1 (BAK1))
    Bindungsspezifität
    • 19
    • 16
    • 8
    • 7
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 79
    • 32
    • 23
    • 16
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Human, Maus
    Wirt
    • 72
    • 5
    • 2
    • 1
    Kaninchen
    Klonalität
    • 64
    • 16
    Polyklonal
    Konjugat
    • 46
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BAK1 Antikörper ist unkonjugiert
    Applikation
    • 69
    • 27
    • 27
    • 19
    • 14
    • 14
    • 13
    • 13
    • 8
    • 7
    • 5
    • 3
    • 1
    • 1
    Western Blotting (WB), Immunocytochemistry (ICC)
    Verwendungszweck
    Rabbit polyclonal antibody raised against synthetic peptide of BAK1.
    Kreuzreaktivität
    Human, Maus
    Immunogen
    A synthetic peptide corresponding to N-terminus 13 amino acids of human BAK1.
    Top Product
    Discover our top product BAK1 Primärantikörper
  • Applikationshinweise
    Western Blot (1-2 μg/mL)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    In PBS (0.02 % sodium azide)
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for three months. For long term storage store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Bamodu, Huang, Tzeng, Wu, Wang, Yeh, Chao: "Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity." in: Cancer letters, Vol. 364, Issue 2, pp. 125-34, (2015) (PubMed).

    Heiser, Labi, Erlacher, Villunger: "The Bcl-2 protein family and its role in the development of neoplastic disease." in: Experimental gerontology, Vol. 39, Issue 8, pp. 1125-35, (2004) (PubMed).

    Cory, Huang, Adams: "The Bcl-2 family: roles in cell survival and oncogenesis." in: Oncogene, Vol. 22, Issue 53, pp. 8590-607, (2003) (PubMed).

  • Target
    BAK1 (BCL2-Antagonist/killer 1 (BAK1))
    Andere Bezeichnung
    Bcl-2-like 7 (BAK1 Produkte)
    Synonyme
    BAK antikoerper, BAK-LIKE antikoerper, BCL2L7 antikoerper, CDN1 antikoerper, Bak antikoerper, N-BAK1 antikoerper, N-Bak antikoerper, Bak1 antikoerper, bak antikoerper, bak1 antikoerper, BCL2 antagonist/killer 1 antikoerper, BCL2-antagonist/killer 1 antikoerper, BCL2 antagonist/killer 1 L homeolog antikoerper, BAK1 antikoerper, Bak1 antikoerper, bak1.L antikoerper
    Gen-ID
    578
    Pathways
    Apoptose, Steroid Hormone Mediated Signaling Pathway, ER-Nucleus Signaling, Positive Regulation of Endopeptidase Activity, Unfolded Protein Response
Sie sind hier:
Kundenservice